StockData
Picard Medical, Inc. logo

Picard Medical, Inc. (PMI) stock

PMINYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 7/3062% above fair value
$8.04−0.01 (-0.12%)

Close on Nov 11, 2026Market cap $18.80MP/E –Yield –

Picard Medical, Inc. grew revenue 41.0% to $6.30M over the twelve months to Jun 30, 2026. At the latest close the market valued the company at $18.80M.

Revenue
$6.30M
+41.0% vs. a year earlier
Operating income
-$15.63M
TTM Q2 2026

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026

Valuation

Market cap
$18.80M
P/E ratio
–
Price to sales
2.98
Price to book
10.96
Dividend yield
–
Free cash flow yield
–

Fundamentals

Revenue
$6.30M
Net income
-$27.99M
Book value per share
$0.92
Diluted shares
2M

Trading

Previous close
$8.05
Open
$8.22
Day's range
$7.80 – $8.26
Volume
16,666
Average volume (20 days)
316,962
52-week range
$2.65 – $208.00
RSI (14 days)
49.3
Volatility (1 year)
223.9%
Relative volume
0.01×

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.

PeriodPMIS&P 500DifferencePMI per yearS&P 500 per year
1 month-15.2%-2.4%−12.8 pts
3 months+121.5%-1.2%+122.6 pts
Year to date-90.8%+12.3%−103.1 pts
1 year-94.4%+12.4%−106.8 pts

Three years at a glance

Fiscal years 2023 to 2025 and trailing twelve months, USD

Revenue

$6.30M+41.0% YoY

Gross profit

$1.17M

Operating income

-$15.63M

Net income

-$27.99M
Reported periodTrailing twelve months

Press releases

Releases Picard Medical filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About Picard Medical

Surgical & Medical Instruments & Apparatus

Picard Medical, Inc., operating primarily through its subsidiary SynCardia Systems, LLC, is a medical technology company specializing in mechanical circulatory support. The company manufactures and commercializes total artificial heart systems designed to replace the function of failing ventricles and valves in patients with end-stage biventricular heart failure. Its core product offering includes the 50cc and 70cc artificial heart implants paired with external pneumatic power systems: the mobile Companion 2 Driver for clinical inpatient stabilization and the lightweight Freedom Driver for outpatient home care. These devices serve primarily as a bridge to heart transplantation for hospitals, cardiac transplant centers, and surgeons treating critically ill patients.

Company profile, executives and history

Picard Medical stock: common questions

What is Picard Medical's stock price?

PMI closed at $8.04 on Nov 11, 2026, down 0.12% on the day. Over the past 52 weeks it traded between $2.65 and $208.00.

What is Picard Medical's market cap?

Picard Medical was worth $18.80M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.

How much revenue does Picard Medical make?

Picard Medical reported revenue of $6.30M for the twelve months to Jun 30, 2026, up 41.0% from a year earlier.

Does Picard Medical pay a dividend?

No. Picard Medical has not paid a cash dividend over the last twelve months.

How has PMI stock performed over the past year?

Including dividends, PMI returned -94.4% over the past year, against +12.4% for the S&P 500.

Who are Picard Medical's competitors?

Companies most similar to Picard Medical by business, industry and size include EBRCZ, XAIR, NSPR, MDNC, BTCY.

See a number that looks wrong?